Related Experiment Video
Updated: Jun 19, 2025

Autonomous and Rechargeable Microneurostimulator Endoscopically Implantable into the Submucosa
Published on: September 27, 2018
Electroceuticals and Magnetoceuticals in Gastroenterology
Gengqing Song1, Roberta Sclocco2,3, Amol Sharma4
1Division of Gastroenterology & Hepatology, MetroHealth Medical Center, Case Western Reserve University, Cleveland, OH 44109, USA.
Neuromodulation techniques like vagal nerve stimulation and acupuncture offer promising alternatives for gastrointestinal (GI) motility disorders and inflammatory bowel disease (IBD). These methods target the nervous system to improve GI function and reduce inflammation, addressing limitations of current treatments.
Area of Science:
- Gastroenterology
- Neurogastroenterology
- Translational Medicine
Background:
- Current treatments for gastrointestinal (GI) motility disorders and inflammatory bowel disease (IBD) are often inadequate and may cause side effects.
- There is a critical need for novel therapeutic strategies to manage these complex GI conditions.
Purpose of the Study:
- To review the potential of neuromodulation techniques as alternative therapies for GI motility disorders and IBD.
- To explore the efficacy of vagal nerve stimulation (VNS), magnetic neuromodulation, and acupuncture in managing these conditions.
Main Methods:
- Review of existing literature on neuromodulation in gastroenterology.
- Analysis of studies investigating VNS, magnetic neuromodulation, and acupuncture for GI motility and inflammation.
Main Results:
- Vagal nerve stimulation (VNS) demonstrates targeted modulation of GI motility and inflammation.
- Magnetic neuromodulation shows promise for non-invasive enhancement of neurophysiological processes, improving GI function.
- Acupuncture and electroacupuncture exhibit comprehensive neuro-immune-endocrine effects, alleviating GI motility and inflammatory symptoms.
Conclusions:
- Neuromodulation presents a promising therapeutic avenue for GI motility disorders and IBD.
- Further research is required to optimize these interventions and develop patient-specific management strategies.
- These novel approaches may establish a new paradigm in the treatment of challenging GI conditions.
Related Concept Videos
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Direct-Acting Cholinergic Agonists: Therapeutic Uses
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...

